Reach |
Who is intended to benefit? |
How do we reach reproductive-aged women in rural kenya? |
A screening strategy offered through community health campaigns in a central location will reach a large proportion of reproductive-aged women. |
How do we reach them? |
Effectiveness |
Is the program effective? |
Are women getting screened for cervical cancer with HPV? |
A community-based strategy allowing for self-testing will be highly acceptable. |
How do we ensure effectiveness? |
Are HPV + women successfully linking to treatment? |
Innovative, patient and provider-designed strategies will increase the number of women linking to care. |
Adoption and Maintenance |
How can strategy be maintained after initial implementation and adopted in similar communities? |
What are the patient, provider and delivery system processes necessary to ensure consistent service provision? |
A screening protocol with a simple, patient-performed test offered as part of a health fair will minimize the costs to the health care system to introduce screening. |
What are the short and long-term health effects in the community? |
What is the population-level health impact of screening using HPV self-testing in the CHCs with enhanced linkage to care? |
The high number of at -risk women reached through the CHC-base strategy with enhanced linkage to care would produce a greater population-level health impact. |
Implementation |
What is adherence to the implementation strategy at the delivery level? |
Is HPV testing being offered and delivered consistently at the CHC and clinic sites? |
Providing testing in a high-volume CHC will reach a large number of women with low staffing and infrastructure needs, and will therefore have a lower cost per woman treated than a standard strategy. |
What are the costs of implementation? |
What is the cost per lesion treated? |